- Home
- BTSG vs APGE Comparison
BTSG vs APGE Comparison
Compare BTSG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- APGE
- Stock Information
- Founded
- BTSG 1974
- APGE 2022
- Country
- BTSG United States
- APGE United States
- Employees
- BTSG N/A
- APGE N/A
- Industry
- BTSG
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTSG
- APGE Health Care
- Exchange
- BTSG NYSE
- APGE Nasdaq
- Market Cap
- BTSG 2.0B
- APGE 1.8B
- IPO Year
- BTSG 2024
- APGE 2023
- Fundamental
- Price
- BTSG $16.87
- APGE $39.31
- Analyst Decision
- BTSG Strong Buy
- APGE Strong Buy
- Analyst Count
- BTSG 9
- APGE 5
- Target Price
- BTSG $22.13
- APGE $83.50
- AVG Volume (30 Days)
- BTSG 1.7M
- APGE 697.5K
- Earning Date
- BTSG 03-06-2025
- APGE 03-03-2025
- Dividend Yield
- BTSG N/A
- APGE N/A
- EPS Growth
- BTSG N/A
- APGE N/A
- EPS
- BTSG N/A
- APGE N/A
- Revenue
- BTSG $11,266,472,000.00
- APGE N/A
- Revenue This Year
- BTSG $7.77
- APGE N/A
- Revenue Next Year
- BTSG $10.64
- APGE N/A
- P/E Ratio
- BTSG N/A
- APGE N/A
- Revenue Growth
- BTSG 27.65
- APGE N/A
- 52 Week Low
- BTSG $7.85
- APGE $29.10
- 52 Week High
- BTSG $24.82
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- BTSG 39.90
- APGE 56.74
- Support Level
- BTSG $15.92
- APGE $29.10
- Resistance Level
- BTSG $19.05
- APGE $35.20
- Average True Range (ATR)
- BTSG 1.00
- APGE 2.91
- MACD
- BTSG -0.28
- APGE 1.14
- Stochastic Oscillator
- BTSG 40.17
- APGE 73.84
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.